SCA Pharma, an FDA-registered outsourcing facility, plans to expand its sterile pharmaceutical manufacturing facility in Windsor, CT, by 40 percent. It currently operates two sterile pharmaceutical manufacturing facilities located in Windsor and Little Rock, AK. The planned expansion would increase the size of the Windsor facility to approximately 150,000 square feet with the ability to add state-of-the-art automation, compounding capability, and technical employees to manufacture critical medicines.  
 
“Ensuring that hospitals have all of the readily available sterile injectable pharmaceuticals they need to properly treat and care for patients is more critical today than ever before,” said Milton Boyer, chief executive officer, SCA Pharma. “The demand for SCA products continues to increase, and we are committed to meeting that need safely, efficiently and reliably. Our new construction will position us to expand our capacity and make products even more accessible to hospitals.”
 
Boyer said construction would take approximately nine months to complete.